v3.25.2
FAIR VALUE MEASUREMENTS (Tables)
 12 Months Ended
Jun. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Assets at Fair Value on a Recurring Basis
The following table represents the Company's financial assets and liabilities, which are measured at fair value on a recurring basis (in thousands):
Fair Value of Financial Assets and LiabilitiesQuoted Prices in Active Markets for Identical Assets
(Level 1)		Significant Other Observable Inputs
(Level 2)		Significant Unobservable Inputs
(Level 3)
June 30, 2025
Deferred compensation plan assets$53,850 $53,850 $— $— 
Total assets53,850 53,850 — — 
Earn-out liabilities7,706 — — 7,706 
Total liabilities$7,706 $— $— $7,706 
June 30, 2024
Deferred compensation plan assets$61,198 $61,198 $— $— 
Total assets61,198 61,198 — — 
Earn-out liabilities28,549 — — 28,549 
Total liabilities$28,549 $— $— $28,549 
Schedule of Reconciliation Earn-Out Liabilities and FFF Put and Call Rights
A reconciliation of the Company’s Level 3 earn-out liabilities is as follows (in thousands):
Year Ended June 30,
202520242023
Beginning balance$28,549 $26,603 $22,789 
(Settlements) purchases (a)
(19,294)(1,375)1,460 
(Gains) losses (b)
(1,549)3,321 2,354 
Ending balance$7,706 $28,549 $26,603 
_________________________________
(a)Settlements for the years ended June 30, 2025 and 2024 represent payments on earn-out liabilities. Purchases for the year ended June 30, 2025 represent the earn-out associated with the IllumiCare acquisition. Purchases for the year ended June 30, 2023 include an earn-out which had not been earned or paid as of June 30, 2023.
(b)Gains on level 3 liability balances will decrease the liability ending balance and losses on level 3 liability balances will increase the liability ending balance. (Gains) losses on earn-out liabilities are included in selling, general, and administrative expenses on the Consolidated Statements of Income and Comprehensive Income.